Men who have a certain type of prostate cancer may benefit from PROVENGE® (sipuleucel-T). This medicine is created by taking a man's own immune cells and mixing them with a protein that activates them to attack prostate cancer cells. PROVENGE is sometimes called a vaccine for prostate cancer because it activates the immune system.
However, unlike vaccines used to prevent diseases, PROVENGE is used to treat prostate cancer that already exists in the body. It is not used to prevent prostate cancer.
(Click PROVENGE for more information on this cancer vaccine, including potential side effects, general dosing guidelines, and more.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
PROVENGE Web site. Available at: http://www.provenge.com. Accessed July 13, 2011.
Food and Drug Administration Web site. Vaccines, Blood and Biologics, Approved Products. PROVENGE. Available at: http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm210012.htm. Accessed July 13, 2011.
Food and Drug Administration Web site. Vaccines, Blood and Biologics, Resources for Healthcare Providers. Available at: http://www.fda.gov/BiologicsBloodVaccines/ResourcesforYou/HealthcareProviders/default.htm. Access July 13, 2011.
Food and Drug Administration Web site. Vaccines, Blood and Biologics, Questions and Answers about PROVENGE. Available at: http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm210037.htm. Accessed July 13, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click